Index S&P 500
P/E 26.34
EPS (ttm) 2.41
Insider Own 0.88%
Shs Outstand 222.22M
Perf Week -4.84%
Market Cap 14.12B
Forward P/E 14.07
EPS next Y 4.51
Insider Trans 0.28%
Shs Float 220.46M
Perf Month -6.37%
Enterprise Value 14.76B
PEG 3.86
EPS next Q 1.10
Inst Own 100.84%
Short Float 1.42%
Perf Quarter -2.59%
Income 557.10M
P/S 3.50
EPS this Y 3.98%
Inst Trans -1.39%
Short Ratio 1.67
Perf Half Y 2.70%
Sales 4.04B
P/B 2.91
EPS next Y 6.36%
ROA 6.30%
Short Interest 3.12M
Perf YTD -11.93%
Book/sh 21.79
P/C 7.51
EPS next 5Y 6.83%
ROE 11.38%
52W High 84.39 -24.77%
Perf Year -21.05%
Cash/sh 8.45
P/FCF 15.15
EPS past 3/5Y -22.74% -
ROIC 7.57%
52W Low 51.90 22.33%
Perf 3Y -8.20%
Dividend Est. -
EV/EBITDA 11.84
Sales past 3/5Y -10.56% 3.66%
Gross Margin 55.93%
Volatility 1.87% 1.79%
Perf 5Y 7.19%
Dividend TTM -
EV/Sales 3.66
EPS Y/Y TTM -17.73%
Oper. Margin 23.58%
ATR (14) 1.21
Perf 10Y 60.05%
Dividend Ex-Date -
Quick Ratio 2.81
Sales Y/Y TTM 1.28%
Profit Margin 13.79%
RSI (14) 34.42
Recom 2.30
Dividend Gr. 3/5Y - -
Current Ratio 3.55
EPS Q/Q 5.09%
SMA20 -4.46%
Beta 0.62
Target Price 74.00
Payout 0.00%
Debt/Eq 0.52
Sales Q/Q 1.23%
SMA50 -4.30%
Rel Volume 0.66
Prev Close 63.80
Employees 7063
LT Debt/Eq 0.52
Earnings Jul 30 AMC
SMA200 -2.78%
Avg Volume 1.87M
Price 63.49
IPO Mar 01, 1990
Option/Short Yes / Yes
EPS/Sales Surpr. 1.52% 1.32%
Trades
Volume 320,528
Change -0.49%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-18-25 Upgrade
Argus
Hold → Buy
$80
Aug-06-25 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$87
Jul-09-25 Upgrade
Citigroup
Neutral → Buy
$80
May-27-25 Reiterated
Needham
Hold
Mar-03-25 Downgrade
Argus
Buy → Hold
Feb-06-25 Downgrade
Leerink Partners
Outperform → Market Perform
$80 → $75
Feb-03-25 Downgrade
Needham
Buy → Hold
Dec-13-24 Initiated
Wolfe Research
Peer Perform
Dec-10-24 Reiterated
Needham
Buy
$90
Dec-10-24 Initiated
Jefferies
Hold
$85
Oct-01-24 Downgrade
Citigroup
Buy → Neutral
$95 → $85
Jun-27-24 Initiated
Stephens
Overweight
$87
Apr-03-24 Upgrade
Citigroup
Neutral → Buy
$80 → $95
Jul-14-23 Upgrade
Needham
Hold → Buy
$95
Dec-07-22 Initiated
RBC Capital Mkts
Sector Perform
$75
Oct-13-22 Initiated
Mizuho
Buy
$75
Jul-20-22 Initiated
UBS
Neutral
$73
Jul-20-22 Downgrade
BofA Securities
Buy → Neutral
$81 → $75
Jul-18-22 Downgrade
BTIG Research
Buy → Neutral
Apr-25-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$75
Show Previous Ratings
Today 09:40AM
Sep-15-25 09:00AM
Sep-11-25 07:50AM
Sep-10-25 05:45PM
10:06AM
07:04AM
Loading…
Sep-09-25 07:04AM
Sep-08-25 04:32PM
Sep-04-25 08:47AM
Sep-03-25 04:02PM
Aug-29-25 11:30AM
08:06AM
Aug-26-25 09:00AM
Aug-25-25 08:31AM
Aug-21-25 09:50AM
Aug-20-25 09:40AM
09:00AM
Loading…
09:00AM
Aug-15-25 09:00AM
Aug-14-25 02:41AM
Aug-13-25 08:25AM
Aug-12-25 11:55PM
11:53PM
04:49AM
Aug-11-25 07:30AM
Aug-08-25 08:43AM
Aug-06-25 07:38AM
Aug-05-25 09:50AM
09:04AM
Aug-04-25 09:40AM
09:15AM
09:00AM
08:50AM
Loading…
Aug-01-25 08:50AM
Jul-31-25 07:59AM
05:10AM
03:31AM
Jul-30-25 05:30PM
05:10PM
04:08PM
(Associated Press Finance)
04:06PM
04:01PM
Jul-29-25 08:05AM
04:02AM
Jul-28-25 11:18PM
Jul-25-25 09:22AM
09:15AM
08:38AM
Jul-24-25 09:06AM
Jul-23-25 04:30AM
[Latest] Global Inferior Vena Cava IVC Filter Market Size/Share Worth USD 2,094.10 Million by 2034 at a 8.88% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)
(GlobeNewswire)
Jul-22-25 05:45PM
08:32AM
Jul-16-25 08:55AM
Jul-15-25 05:45PM
12:08PM
09:00AM
Jul-14-25 04:11PM
Jul-11-25 04:07AM
Jul-10-25 08:25AM
Jul-09-25 05:45PM
Jul-08-25 08:31AM
Jul-04-25 09:00AM
Jul-02-25 04:05PM
09:35AM
Jun-26-25 05:45PM
04:08AM
Jun-25-25 09:13AM
Jun-23-25 09:32AM
09:00AM
Jun-20-25 06:41AM
Jun-17-25 05:45PM
Jun-16-25 08:30AM
Jun-11-25 08:29AM
Jun-10-25 08:04PM
09:00AM
Jun-09-25 08:42AM
Jun-04-25 08:41AM
May-30-25 09:00AM
May-28-25 05:16PM
04:29AM
May-27-25 11:35PM
05:22PM
04:07PM
02:04PM
08:24AM
May-22-25 05:05PM
May-21-25 12:01AM
May-19-25 09:00AM
May-15-25 04:46PM
May-13-25 04:10PM
09:16AM
May-12-25 08:44AM
May-07-25 12:16PM
May-06-25 09:00AM
12:32AM
May-02-25 02:25PM
(Morningstar Research) -5.45%
11:57AM
10:11AM
(Thomson Reuters StreetEvents)
07:25AM
03:15AM
May-01-25 08:24PM
05:30PM
05:10PM
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products, that focuses on women's health and well-being through early detection and treatment. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. The Diagnostics segment offers a range of products, which are used primarily to aid in the screening and diagnosis of human diseases. The GYN Surgical segment is involved in hysteroscopic endometrial ablation systems, tissue removal systems, fluid management systems, and laparoscopic tissue ablation systems and tools. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Madaus Martin D Director May 07 '25 Buy 55.24 5,445 300,760 5,445 May 09 04:39 PM Mitchell Essex D Chief Operating Officer Dec 04 '24 Option Exercise 62.60 22,902 1,433,659 52,813 Dec 06 04:28 PM Mitchell Essex D Chief Operating Officer Dec 04 '24 Sale 76.34 24,856 1,897,482 27,957 Dec 06 04:28 PM Mitchell Essex D Officer Dec 04 '24 Proposed Sale 76.34 24,856 1,897,484 Dec 04 12:24 PM